Showing 10,121 - 10,140 results of 226,405 for search '(( a ((((mean decrease) OR (a decrease))) OR (linear decrease)) ) OR ( a large decrease ))', query time: 1.14s Refine Results
  1. 10121

    DNA Methylation in <i>Cosmc</i> Promoter Region and Aberrantly Glycosylated IgA1 Associated with Pediatric IgA Nephropathy by Qiang Sun (225630)

    Published 2015
    “…After treatment with IL-4, the levels of <i>Cosmc</i> DNA methylation and aberrantly glycosylated IgA1 in IgAN lymphocytes were remarkably higher than the other two groups (<i>P</i><0.0001) with more markedly decreased Cosmc mRNA content (<i>P</i><0.0001). …”
  2. 10122

    Structure-Based Design of Inhibitors with Improved Selectivity for Steroidogenic Cytochrome P450 17A1 over Cytochrome P450 21A2 by Charlie Fehl (1945474)

    Published 2018
    “…Docking these analogs into CYP21A2 identified steric clashes that likely underlie decreased binding and CYP21A2 inhibition. …”
  3. 10123

    Structure-Based Design of Inhibitors with Improved Selectivity for Steroidogenic Cytochrome P450 17A1 over Cytochrome P450 21A2 by Charlie Fehl (1945474)

    Published 2018
    “…Docking these analogs into CYP21A2 identified steric clashes that likely underlie decreased binding and CYP21A2 inhibition. …”
  4. 10124

    Structure-Based Design of Inhibitors with Improved Selectivity for Steroidogenic Cytochrome P450 17A1 over Cytochrome P450 21A2 by Charlie Fehl (1945474)

    Published 2018
    “…Docking these analogs into CYP21A2 identified steric clashes that likely underlie decreased binding and CYP21A2 inhibition. …”
  5. 10125

    Structure-Based Design of Inhibitors with Improved Selectivity for Steroidogenic Cytochrome P450 17A1 over Cytochrome P450 21A2 by Charlie Fehl (1945474)

    Published 2018
    “…Docking these analogs into CYP21A2 identified steric clashes that likely underlie decreased binding and CYP21A2 inhibition. …”
  6. 10126

    Structure-Based Design of Inhibitors with Improved Selectivity for Steroidogenic Cytochrome P450 17A1 over Cytochrome P450 21A2 by Charlie Fehl (1945474)

    Published 2018
    “…Docking these analogs into CYP21A2 identified steric clashes that likely underlie decreased binding and CYP21A2 inhibition. …”
  7. 10127

    Structure-Based Design of Inhibitors with Improved Selectivity for Steroidogenic Cytochrome P450 17A1 over Cytochrome P450 21A2 by Charlie Fehl (1945474)

    Published 2018
    “…Docking these analogs into CYP21A2 identified steric clashes that likely underlie decreased binding and CYP21A2 inhibition. …”
  8. 10128

    Structure-Based Design of Inhibitors with Improved Selectivity for Steroidogenic Cytochrome P450 17A1 over Cytochrome P450 21A2 by Charlie Fehl (1945474)

    Published 2018
    “…Docking these analogs into CYP21A2 identified steric clashes that likely underlie decreased binding and CYP21A2 inhibition. …”
  9. 10129

    Structure-Based Design of Inhibitors with Improved Selectivity for Steroidogenic Cytochrome P450 17A1 over Cytochrome P450 21A2 by Charlie Fehl (1945474)

    Published 2018
    “…Docking these analogs into CYP21A2 identified steric clashes that likely underlie decreased binding and CYP21A2 inhibition. …”
  10. 10130

    Structure-Based Design of Inhibitors with Improved Selectivity for Steroidogenic Cytochrome P450 17A1 over Cytochrome P450 21A2 by Charlie Fehl (1945474)

    Published 2018
    “…Docking these analogs into CYP21A2 identified steric clashes that likely underlie decreased binding and CYP21A2 inhibition. …”
  11. 10131

    Structure-Based Design of Inhibitors with Improved Selectivity for Steroidogenic Cytochrome P450 17A1 over Cytochrome P450 21A2 by Charlie Fehl (1945474)

    Published 2018
    “…Docking these analogs into CYP21A2 identified steric clashes that likely underlie decreased binding and CYP21A2 inhibition. …”
  12. 10132

    Structure-Based Design of Inhibitors with Improved Selectivity for Steroidogenic Cytochrome P450 17A1 over Cytochrome P450 21A2 by Charlie Fehl (1945474)

    Published 2018
    “…Docking these analogs into CYP21A2 identified steric clashes that likely underlie decreased binding and CYP21A2 inhibition. …”
  13. 10133

    Structure-Based Design of Inhibitors with Improved Selectivity for Steroidogenic Cytochrome P450 17A1 over Cytochrome P450 21A2 by Charlie Fehl (1945474)

    Published 2018
    “…Docking these analogs into CYP21A2 identified steric clashes that likely underlie decreased binding and CYP21A2 inhibition. …”
  14. 10134

    Structure-Based Design of Inhibitors with Improved Selectivity for Steroidogenic Cytochrome P450 17A1 over Cytochrome P450 21A2 by Charlie Fehl (1945474)

    Published 2018
    “…Docking these analogs into CYP21A2 identified steric clashes that likely underlie decreased binding and CYP21A2 inhibition. …”
  15. 10135

    Structure-Based Design of Inhibitors with Improved Selectivity for Steroidogenic Cytochrome P450 17A1 over Cytochrome P450 21A2 by Charlie Fehl (1945474)

    Published 2018
    “…Docking these analogs into CYP21A2 identified steric clashes that likely underlie decreased binding and CYP21A2 inhibition. …”
  16. 10136

    Structure-Based Design of Inhibitors with Improved Selectivity for Steroidogenic Cytochrome P450 17A1 over Cytochrome P450 21A2 by Charlie Fehl (1945474)

    Published 2018
    “…Docking these analogs into CYP21A2 identified steric clashes that likely underlie decreased binding and CYP21A2 inhibition. …”
  17. 10137

    Meta-analytical results of secondary outcomes. by Maria-Sophie Brueckle (13816408)

    Published 2023
    “…ID=CRD42020111970" target="_blank">CRD42020111970</a>.</p></div>…”
  18. 10138

    Study characteristics. by Maria-Sophie Brueckle (13816408)

    Published 2023
    “…ID=CRD42020111970" target="_blank">CRD42020111970</a>.</p></div>…”
  19. 10139

    Forest plots of primary outcomes. by Maria-Sophie Brueckle (13816408)

    Published 2023
    “…ID=CRD42020111970" target="_blank">CRD42020111970</a>.</p></div>…”
  20. 10140